15367512

Source:http://linkedlifedata.com/resource/pubmed/id/15367512

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023759, umls-concept:C0030705, umls-concept:C0082608, umls-concept:C0340288, umls-concept:C0443343, umls-concept:C0522523, umls-concept:C0591720, umls-concept:C1274040, umls-concept:C1280500, umls-concept:C1522318, umls-concept:C1706420, umls-concept:C1948041
pubmed:issue	10
pubmed:dateCreated	2004-9-15
pubmed:abstractText	To investigate the effect on risk of major adverse cardiac events (MACE) of lipid lowering treatment with fluvastatin 80 mg/day after a first percutaneous coronary intervention in patients with stable and unstable angina.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-10385495, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-10411845, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-10481532, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-10974215, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11058714, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11130382, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11150621, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11152415, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11249901, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11277825, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11297956, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11427206, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11532902, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11689203, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11728357, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11779513, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11943939, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11950426, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-11978335, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-12071579, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-12076217, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-12081988, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-3948352, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-3971539, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-7586300, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-8041413, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-8801446, http://linkedlifedata.com/resource/pubmed/commentcorrection/15367512-9841303
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1468-201X
pubmed:author	pubmed-author:CicconeMM, pubmed-author:CortellaroMM, pubmed-author:GoedhartDD, pubmed-author:LeeC HCH, pubmed-author:LemonP JPJ, pubmed-author:SaidII, pubmed-author:SerruysP WPW, pubmed-author:SoaresP RPR, pubmed-author:UmansV A W MVA, pubmed-author:de FeyterPP
pubmed:issnType	Electronic
pubmed:volume	90
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1156-61
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15367512-Adolescent, pubmed-meshheading:15367512-Adult, pubmed-meshheading:15367512-Aged, pubmed-meshheading:15367512-Aged, 80 and over, pubmed-meshheading:15367512-Angina, Unstable, pubmed-meshheading:15367512-Angina Pectoris, pubmed-meshheading:15367512-Angioplasty, Balloon, Coronary, pubmed-meshheading:15367512-Cardiovascular Diseases, pubmed-meshheading:15367512-Fatty Acids, Monounsaturated, pubmed-meshheading:15367512-Female, pubmed-meshheading:15367512-Humans, pubmed-meshheading:15367512-Hypolipidemic Agents, pubmed-meshheading:15367512-Indoles, pubmed-meshheading:15367512-Male, pubmed-meshheading:15367512-Middle Aged, pubmed-meshheading:15367512-Postoperative Period, pubmed-meshheading:15367512-Prospective Studies
pubmed:year	2004
pubmed:articleTitle	Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS).
pubmed:affiliation	Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands. leerch@hotmail.com
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study